|
CN110818704A
|
|
Spiro-bridged ring compounds, pharmaceutical compositions thereof and uses thereof
|
|
CN110526929A
|
|
Heteroaromatic compounds, its pharmaceutical composition and its application
|
|
CN111909202A
|
|
Nimodipine phosphate derivative, pharmaceutical composition and application thereof
|
|
WO2019134680A1
|
|
Inhibitor of apoptosis signal-regulating kinase-1 and application thereof
|
|
WO2019037791A1
|
|
Long-acting rasagiline prodrug, preparation method and use thereof
|
|
WO2019029620A1
|
|
Atx inhibitors, preparation method therefor and applications thereof
|
|
CN109575026A
|
|
Long-acting Entecavir prodrug and its preparation method and application
|
|
CN109528632A
|
|
Nimodipine pharmaceutical composition, nimotop vial and preparation method thereof
|
|
CN107311968A
|
|
Citalopram handkerchief not hydrochlorate and its crystal habit and its production and use
|
|
CN108456208A
|
|
Aza toroid compound and its preparation method and application
|
|
CN108341822A
|
|
Fxr receptor modulators and its preparation method and application
|
|
CN106496100A
|
|
Cyclohexene compound and application thereof
|
|
CN107540624A
|
|
Heat shock protein inhibitors and its preparation method and application
|
|
CN107325040A
|
|
Cyclohexene derivative or its pharmaceutically acceptable salt and application thereof
|
|
CN106946867A
|
|
FXR receptor modulators and its production and use
|
|
CN105669532A
|
|
Nimodipine water-soluble derivative, preparation method and application thereof
|
|
CN106146412A
|
|
Quinazoline derivant and its preparation method and application
|
|
CN105982889A
|
|
Medicinal composition capable of resisting influenza viruses and applications of medicinal composition
|
|
CN105713057A
|
|
Scutellarin compounds and preparation method and application thereof
|
|
CN105646629A
|
|
L-nucleoside compounds and application thereof
|
